Herpes Zoster in Children with Risk Factors for a Complicated Disease Course

Clinical Scenario

This protocol targets paediatric patients who present with herpes zoster alongside risk factors that raise the likelihood of a complicated disease course. Age is a defining dimension of this sub-population, and its interaction with other identified risk factors shapes the management threshold.

      When risk factors for a complicated course are present, the approach differs meaningfully from routine childhood herpes zoster. An individualised assessment — weighing potential therapeutic benefit against potential risk — is central to decision-making in these patients.
    

Treatment Approach (partial — full regimen in protocol)

Systemic antiviral therapy enters consideration in this setting, but only when risk factors for a complicated disease course are confirmed. It is applied with caution, and the decision to treat rests on a careful benefit-versus-risk evaluation specific to each patient. The complete decision algorithm and all further details are available in the structured protocol below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1111/ddg.14013

In the presence of risk factors for a complicated disease course, systemic antiviral therapy may be recommended for children with herpes zoster, if the therapeutic benefits outweigh any potential risks.

View source ↗